Preparation method and preparation intermediate of fingolimod hydrochloride

A technology for fingolimod hydrochloride and an intermediate, which is applied in the field of pharmaceutical synthesis, can solve the problems of column purification, complicated operation, low yield and the like, and achieves the effects of easy industrial production, advanced preparation technology and cost reduction.

Inactive Publication Date: 2015-04-22
湖北金赛药业有限公司
View PDF9 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] CN1483721A then adopts a kind of method of newly constructing the structure of aminopropanediol on the basis of this thinking, after it obtains 4-(2-halogenated ethyl) octylbenzene, it and malonic acid ester under alkaline condition Condensation, followed by steps such as nitrosation and reduction to obtain FTY-720, the total yield is relatively high (about 28%), but the overa

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and preparation intermediate of fingolimod hydrochloride
  • Preparation method and preparation intermediate of fingolimod hydrochloride
  • Preparation method and preparation intermediate of fingolimod hydrochloride

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0032] Example one

[0033] step 1

[0034] In a 250mL three-necked flask, add 19g (0.1mol) n-octylbenzene, 13.3g (0.1mol) aluminum trichloride, 35mL dichloromethane, cool to -10℃, drop 11.3g (0.1mol) chloroacetyl chloride to dissolve in A solution of 30 mL of dichloromethane was added at a temperature between 0° C., and after the addition was completed, stirred at room temperature for 2 hours. Pour the reaction solution into 200 mL ice water with stirring, separate the organic phase, extract the aqueous phase with 50 mL dichloromethane, combine the organic phases, wash twice with water, dry with anhydrous magnesium sulfate, filter and concentrate, and add 30 mL petroleum ether to the residue Place it in the refrigerator overnight, and filter the precipitated solid to obtain 17 g of white solid (Compound A).

[0035] Step 2

[0036] In a 500mL three-necked flask, add 200mL of absolute ethanol, cut 4.6 (0.2mol) g of metallic sodium into small pieces and slowly add them to the absolut...

Example Embodiment

[0048] Example two

[0049] step 1

[0050] In a 250mL three-necked flask, add 19g (0.1mol) n-octylbenzene, 13.3g (0.1mol) aluminum trichloride, 35mL dichloromethane, cool to -10℃, drop 11.3g (0.1mol) chloroacetyl chloride to dissolve in A solution of 30 mL of dichloromethane, the temperature of the dropwise addition is between -5-0°C, and after the dropwise addition is completed, stir at room temperature for 2 hours. Pour the reaction solution into 200 mL ice water with stirring, separate the organic phase, extract the aqueous phase with 50 mL dichloromethane, combine the organic phases, wash twice with water, dry with anhydrous magnesium sulfate, filter and concentrate, and add 30 mL petroleum ether to the residue Place it in the refrigerator overnight, and filter the precipitated solid to obtain 17.2 g of white solid (Compound A).

[0051] Step 2

[0052] In a 500mL three-necked flask, add 200mL of absolute ethanol, cut 4.6 (0.2mol) g of metallic sodium into small pieces and slow...

Example Embodiment

[0064] Example three

[0065] step 1

[0066] In a 250mL three-necked flask, add 19g (0.1mol) n-octylbenzene, 13.3g (0.1mol) aluminum trichloride, 35mL dichloromethane, cool to -10℃, drop 11.3g (0.1mol) chloroacetyl chloride to dissolve in A solution of 30 mL of dichloromethane, the temperature of the dropwise addition is between -10 and 5°C, after the dropwise addition is completed, stir at room temperature for 2 hours. Pour the reaction solution into 200 mL ice water with stirring, separate the organic phase, extract the aqueous phase with 50 mL dichloromethane, combine the organic phases, wash twice with water, dry with anhydrous magnesium sulfate, filter and concentrate, and add 30 mL petroleum ether to the residue Place it in the refrigerator overnight, and filter the precipitated solid to obtain 17.3 g of white solid (Compound A).

[0067] Step 2

[0068] In a 500mL three-necked flask, add 200mL of absolute ethanol, cut 4.6 (0.2mol) g of metallic sodium into small pieces and s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of drug synthesis, and specifically relates to a preparation method and a preparation intermediate of fingolimod hydrochloride. The method provides a completely novel synthesis route. According to the method, n-octyl benzene and chloroacetyl chloride are adopted as initial raw materials; and fingolimod hydrochloride is prepared through the steps of Friedel-Crafts acylation, coupling, ketone carbonyl reduction, ester group reduction, amide hydrolysis, hydrochloride formation, and the like. The preparation method is completely novel; preparation process is advanced; yield is high; the method is stable; and cost can be effectively reduced.

Description

technical field [0001] The invention belongs to the field of drug synthesis, and in particular relates to a preparation method of fingolimod hydrochloride and an intermediate thereof. Background technique [0002] Fingolimod hydrochloride is referred to as FTY-720 for short, and its chemical name is 2-(4-octylphenyl)ethyl-2-amino-1,3-propanediol hydrochloride. FTY-720 is an immunosuppressant, mainly For the treatment of relapsing-remitting multiple sclerosis (MS), it was approved by the US FDA on September 21, 2010, becoming the first oral drug for the treatment of relapsing-remitting multiple sclerosis (MS) new immunosuppressant. [0003] At present, there are several methods for synthesizing FTY-720 in the literature: the earliest FTY-720 compound patent US5604229 uses phenethyl acetate as a raw material, first constructs an octyl substituent through Friedel-Crafts acylation, and then converts The ester group is converted into a more active iodine substituent, and the am...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C49/80C07C215/28C07C213/02
Inventor 熊开文赵继舒
Owner 湖北金赛药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap